Literature DB >> 16618426

The changing face of colorectal cancer in inflammatory bowel disease: progress at last!

David T Rubin.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 16618426     DOI： 10.1053/j.gastro.2006.03.015

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  10 in total

1.  Surveillance of dysplasia in inflammatory bowel disease: The gastroenterologist-pathologist partnership.

Authors:  David T Rubin; Jerrold R Turner
Journal:  Clin Gastroenterol Hepatol       Date:  2006-11       Impact factor: 11.382

Review 2.  Ulcerative colitis: diagnosis and management.

Authors:  Paul Collins; Jonathan Rhodes
Journal:  BMJ       Date:  2006-08-12

Review 3.  Risk for colorectal cancer in ulcerative colitis: changes, causes and management strategies.

Authors:  Peter-Laszlo Lakatos; Laszlo Lakatos
Journal:  World J Gastroenterol       Date:  2008-07-07       Impact factor: 5.742

4.  An updated approach to dysplasia in IBD.

Authors:  David T Rubin
Journal:  J Gastrointest Surg       Date:  2008-09-03       Impact factor: 3.452

5.  Clinicopathological features of ulcerative colitis-associated colorectal cancer pointing to efficiency of surveillance colonoscopy in a large retrospective Japanese cohort.

Authors:  Hiroki Matsuoka; Hiroki Ikeuchi; Motoi Uchino; Toshihiro Bando; Yoshio Takesue; Takayuki Nishigami; Naohiro Tomita
Journal:  Int J Colorectal Dis       Date:  2012-10-19       Impact factor: 2.571

6.  miR-143 and miR-145 are downregulated in ulcerative colitis: putative regulators of inflammation and protooncogenes.

Authors:  Joel R Pekow; Urszula Dougherty; Reba Mustafi; Hongyan Zhu; Masha Kocherginsky; David T Rubin; Stephen B Hanauer; John Hart; Eugene B Chang; Alessandro Fichera; Loren J Joseph; Marc Bissonnette
Journal:  Inflamm Bowel Dis       Date:  2011-05-06       Impact factor: 5.325

7.  Overexpression of translocator protein in inflammatory bowel disease: potential diagnostic and treatment value.

Authors:  Mariano A Ostuni; Leeyah Issop; Gabriel Péranzi; Francine Walker; Magali Fasseu; Carole Elbim; Vassilios Papadopoulos; Jean-Jacques Lacapere
Journal:  Inflamm Bowel Dis       Date:  2010-09       Impact factor: 5.325

8.  Gene signature distinguishes patients with chronic ulcerative colitis harboring remote neoplastic lesions.

Authors:  Joel Pekow; Urszula Dougherty; Yong Huang; Edward Gometz; Jeff Nathanson; Greg Cohen; Shawn Levy; Masha Kocherginsky; Nanda Venu; Maria Westerhoff; John Hart; Amy E Noffsinger; Stephen B Hanauer; Roger D Hurst; Alessandro Fichera; Loren J Joseph; Qiang Liu; Marc Bissonnette
Journal:  Inflamm Bowel Dis       Date:  2013-03       Impact factor: 5.325

Review 9.  Colorectal cancer and dysplasia in inflammatory bowel disease.

Authors:  Timothy L Zisman; David T Rubin
Journal:  World J Gastroenterol       Date:  2008-05-07       Impact factor: 5.742

Review 10.  MicroRNA in inflammatory bowel disease: Translational research and clinical implication.

Authors:  Kurt Fisher; Jingmei Lin
Journal:  World J Gastroenterol       Date:  2015-11-21       Impact factor: 5.742
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.